Relevance of MIA and S-100 to monitor BRAF inhibitor (iBRAF) therapy in metastatic melanoma patients.
Miguel F. Sanmamed
No relevant relationships to disclose
Sara Fernandez-Landazuri
No relevant relationships to disclose
Eduardo Castanon
No relevant relationships to disclose
Jose Echeveste
No relevant relationships to disclose
Maria D. Lozano
No relevant relationships to disclose
Miguel A. Idoate
No relevant relationships to disclose
Jose Luis Perez-Gracia
No relevant relationships to disclose
Alvaro Gonzalez
No relevant relationships to disclose
Salvador Martin-Algarra
No relevant relationships to disclose